Skip to main content

Closed

QGEN: Qiagen N.V. Stock Analysis | finqOS

Healthcare · Medical - Diagnostics & Research

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+0.7% / yr

Operating margin24.9%

ROIC8.7%

Financially safe

Strong

Debt / equity0.49×

Interest coverage14.1×

Current ratio3.21×

Valuation

Unrated

P/E ratio21.9×

Dividend yield6.4%

Qiagen N.V.

QGENNew York Stock Exchange·USD·Closed

Qiagen N.V.

QGENNew York Stock Exchange·USD·Closed

$41.40

−0.12%

$41.40

−$0.05 (0.12%)

52W Range

35thpctl

Volume

0.44×avg

Mkt Cap

8.54BUSD

P/E

21.9TTM

Div Yield

6.38%ann

52W Range

35thpctl

Volume

0.44×avg

Market Cap

8.54BUSD

P/E Ratio

21.9TTM

Div Yield

6.38%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings